Abstract
It is generally accepted that, in addition to mechanical factors, humoral actions play a role in the regulation of cardiac myocyte growth. The catecholamines were particularly regarded as “hypertrophy hormones” by some authors [1–12]. Furthermore, the sympathetic nervous system seems to play a role in the pathogenesis of congestive heart failure. Activation of this system with elevated plasma catecholamine level and corresponding consequences for peripheral resistance, cardiac energetics, and adrenergic receptor density is a universal response to impaired cardiac function [13–16]. A direct relation between plasma catecholamine level and mortality in patients with chronic congestive cardiac failure has been demonstrated [3,16]. There seems to be general agreement that the application of full β-agonists, while providing acute hemodynamic improvement, has serious adverse effects in long-term use. With regard to β-adrenergic receptor blockade, beneficial as well as detrimental effects have been reported [17–22].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stanton HC, Brenner G, Mayfield ED. 1969. Studies on isoproterenol-induced cardiomegaly in rats. Am Heart J 77:72–80.
Laks MN, Morady F, Swan HJC. 1973. Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest 64:75–78.
Cohen J. 1974. Role of endocrine factors in the pathogenesis of cardiac hypertrophy. Circ Res 34:1149–1157.
Laks MN. 1976. Norepinephrine — the myocardial hypertrophy hormone? Am Heart J 94:674–675.
Frohlich ED, Tarazi RC. 1979. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol 44:959–962.
Östman-Smith J. 1979. Adaptive changes in the sympathetic nervous system and some effector organs of the rat following long term exercise or cold acclimation and the role of cardiac sympathetic nerves in the genesis of compensatory cardiac hypertrophy. Acta Physiol Scand 477(Suppl):1–118.
Östman-Smith J. 1981. Cardiac sympathetic nerves as a final common pathway in the induction of adaptive cardiac hypertrophy. Clin Sci 61:265–272.
Sen S, Tarazi RC. 1983. Regression of myocardial hypertrophy and influence of adreneregic system. Am J Physiol 244:H97–H101.
Simpson P. 1983. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an α-adrenergic response. J Clin Invest 72:732–735.
Simpson P. 1985. Stimulation of hypertrophy of cultured neonatal rat heart cells through an α1-adrenergic receptor and intcrduction of beating through an α1-adrenergic receptor interaction. Circ Res 56:884–894.
Karliner JS, Simpson PC. 1988. β-adrenoceptor and adenylate cyclase regulation in cardiac myocyte growth. Basic Res Cardiol 83:655–663.
Zierhut W, Zimmer H-G. 1989. Significance of myocardial α- and β-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res 65:1417–1425.
Bristow MR, Ginsburg R, Minobe W, Cubic-Cloiti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. 1982. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 307:205–211.
Ayobe MH, Tarazi RC. 1983. Beta-receptors and contractile reserve in left ventricular hypertrophy. Hypertension 5(Suppl I):192–197.
Dominiak P, Türck D, Fuchs G. 1986. Sympathische Regulationsmechanismen einschließ lich adrenerger Rezeptoren. In: Brisse B, Bender F, eds. Autonome Innervation des Herzens. Darmstadt: Steinkopff Verlag, pp 18–27.
Kübler W, Mäurer W, Dietz R, Schömig B, Opherk D. 1978. Metabolic aspects of compensatory mechanisms in cardiac failure. In: Gross F, ed. Modulation of Sympathetic Tone in the Treatment of Cardiovascular Disease. Bern: H. Huber, pp 167–177.
Shanes J, Casabali B, Blend M. 1986. β-adrenergic blockade in heart failure: Potential mechanism of action. Heart Failure 2:138–146.
Swedberg K, Waagstein F, Hjalmarson A, Wallentin I. 1979. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet 1:1375–1376.
Waagstein F, Caidahl K, Wallentin I, Bergh C-H, Hjalmarson A. 1989. Long-term β-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 80:551–563.
Onegi B. 1987. Bedeutung der adrenergen Stimulation für die Manifestierung einer Herzinsuffizienz beim chronisch druckbelasteten Herzen (Goldblatt II Hypertonic (RHR); spontane Hypertonic (SHR)): Einfluß auf Hypertrophiegrad, Konfiguration und Funktion des Herzcns im Stadium der Präinsuffizienz. Doctoral Thesis, Faculty of Chemistry and Pharmacy, University of Tuebingen.
Dannemann E. 1990. Therapeutische und protektive Effekte einer chronischen Blockade der β-adrenergen Rezeptoren bei spontanhypertensiven Ratten. Doctoral Thesis, Faculty of Medicine, University of Tuebingen.
Schuler B. 1992. Auswirkungen einer Kochsalzbelastung und Blockade der β-adrenergen Rezeptoren auf Struktur und Funktion des linken Ventrikels bei spontan-hypertensiven Ratten. Doctoral Thesis, Faculty of Medicine, University of Tuebingen.
Steins K. 1992. Einfluß eines chronischen Schwimmtrainings und zusätzlicher β-Rezeptor-enblockade auf arteriellen Blutdruck, Morphologic und Funktion des linken Ventrikels. Doctoral Thesis, Faculty of Medicine, University of Tuebingen.
Gülch RW, Jacob R. 1988. Geometrical and muscle phusiological determinants of cardiac stroke volume as evaluated on the basis of model calculations. Basic Res Cardiol 83:476–485.
Jacob R, Gülch RW. 1988. Functional significance of ventricular dilatation. Reconsideration of Linzbach’s concept of chronic heart failure. Basic Res Cardiol 83:461–475.
Jacob R, Dierberger B, Gulch RW, Mall G, Voelker W. 1990. Significance of myocardial and geometric factors for ventricular dynamics. In: Jacob R, Seipel L, Zucker IH, eds. Cardiac Dilatation. New York: Gustav Fischer Stuttgart, pp 99–108.
Jacob R, Dierberger B, Gülch RW, Noma K. 1994. Adaptive alterations in cardiac mass and configuration: Beneficial or detrimental? A quantitative analysis based on the finite element method. In: Nagano M, Takeda N, Dhalla NS, eds. The Adapted Heart. New York: Raven Press, pp 111–123.
Dierberger B. 1993. Finite-Elemente-Simulation der Herzdynamik — Das Herz-größen-Schlagvolumenkonzept. Doctoral Thesis, Faculty of Physics, University of Tuebingen.
Dierberger B, Brändle M, Gülch RW, Jacob R. 1991. Significance of geometrical reference models of the left ventricle for a new concept of evaluation of cardiac pumping function. Basic Res Cardiol 86:186–196.
Kissling G, Gassenmaier T, Wendt-Gallitelli MF, Jacob R. 1977. Pressure-volume relations, elastic modulus, and contractile behaviour of the hypertrophied left ventricle of rats with Goldblatt II hypertension. Pflügers Arch 369:213–221.
Vogt M, Jacob R, Kissling G, Rupp H. 1987. Chronic cardiac reactions II. Mechanical and energetic consequences of myocardial transformation versus ventricular dilatation in the chronically pressure-loaded heart. Basic Res Cardiol 82(Suppl 2): 147–159.
Brändle M. 1990. Einfluß der adrenergen Stimulation und des transmembranären Ca2+-Influx auf Geometrie und Pumpfunktion des chronisch druckbelasteten Herzens. Doctoral Thesis, Faculty of Biology, University of Tuebingen.
Thiedemann K-U, Holubarsch Ch, Medugorac I, Jacob R. 1983. Connective tissue content and myocardial stiffness in pressure overload hypertrophy. A combined study of morphologic, morphometric, biochemical and mechanical parameters. Basic Res Cardiol 78:140–155.
Mall G, Klingel K, Hasslacher Ch, Mann J, Mattfeldt T, Baust H, Waldherr R. 1987. Synergistic effects of diabetes mellitus and renovascular hypertension on the rat heart — stcreological investigations on papillary muscles. Virchows Arch A 411:531.
Medugorac I, Jacob R. 1983. Characterization of left ventricular collagen in the rat. Cardiovasc Res 17:15–21.
Rupp H. 1981. The adaptive changes in the isoenzyme pattern of myosin from hypertrophied rat myocardium as a result of pressure overload and physical training. Basic Res Cardiol 76:79–88.
Student. 1908. The probable error of a mean. Biometrika 6:1–25.
David HA, Hartley HO, Pearson ES. 1954. The distribution of the ratio, in a single normal sample, of range to standard deviation. Biometrika 41:482–493.
Bartlett MS. 1937. Properties of suffiency and statistical tests. Proc R Soc A160:268–282.
Scheffe H. 1953. A method forjudging all contrasts in the analysis of variance. Biometrika 40:87–104.
Kruskall WH, Wallis WA. 1952. Use of ranks in one criterion variance analysis. J Am Stat Assoc 47:583–621.
Nemenyi P. 1963. Distribution-free multilple comparisons. New York: State University of New York, Downstate Medical Center.
Jacob R, Kissling G, Ebrecht G, Jörg E, Rupp H, Takeda N. 1984. Cardiac alterations at the myofibrillar level: Is a redistribution of the myosin isoenzyme pattern decisive for cardiac failure in hemodynamic overload? Eur Heart J 5(Suppl F):13–26.
Jacob R. 1986. Cardiac responses to experimental chronic pressure overload. In: Zanchetti A, Tarazi RC, eds. Handbook of Hypertension, Vol 7 (Pathophysiology of Hypertension — Cardiovascular Aspects). Amsterdam: Elsevier, pp 59–83.
Dietz R, Schömig A, Rascher W, Strasser R, Kübler W. 1980. Enhanced sympathetic activity caused by salt loading in spontaneously hypertensive rats. Clin Sci 59:171s–173s.
Dubus I, Samuel JL, Marotte F, Delcayre C, Rappaport L. 1990. β-adrenergic agonists stimulate the synthesis of noncontractile but not contractile proteins in cultured myocytes isolated from adult rat heart. Circ Res 66:867–874.
Motz W, Strauer BE. 1985. Regression or cardiac hypertrophy after therapy in animal hypertension. J Cardiovas Res 7:S56–S61.
Motz W, Strauer BE. 1985. Prevention of hypertensive hypertrophy by medical therapy: Effects on systolic wall stress and systolic function. Basic Res Cardiol 80:642–652.
Strauer BE, Bayer F, Bredis AM, Motz W. 1985. The influence of sympathetic nervous activity on regression of cardiac hypertrophy. J Hyperten 3(Suppl 4):S39–S44.
Gaudron P, Eilles C, Ertl G, Kochsiek K. 1993. Adaptation to cardiac dysfunction after myocardial infarction. Circulation 87(Suppl IV):IV83–IV89.
Harris P. 1983. Evolution and the cardiac patient. Cardiovasc Res 17:313–319
Harris P. 1983. Evolution and the cardiac patient. Cardiovasc Res 17:373–378
Harris P. 1983. Evolution and the cardiac patient. Cardiovasc Res 17:437–445.
Jacob R. 1991. The functional ambivalence of adaptive processes — Considerations based on the example of the hemodynamically overloaded heart. In: Gülch RW, Kissling G, eds. Current Topics in Heart Failure. Darmstadt: Steinkopff, pp 3–12.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Kluwer Academic Publishers
About this chapter
Cite this chapter
Brändle, M., Dierberger, B., Mall, G., Jacob, R. (1995). Significance of Adrenergic Stimuli for Cardiac Remodeling under Chronic Overload: Relative Importance of Myocardial Factors versus Ventricular Geometry in Cardiac Failure. In: Dhalla, N.S., Pierce, G.N., Panagia, V., Beamish, R.E. (eds) Heart Hypertrophy and Failure. Developments in Cardiovascular Medicine, vol 169. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1237-6_29
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1237-6_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8526-7
Online ISBN: 978-1-4613-1237-6
eBook Packages: Springer Book Archive